Search filters

List of works by George J Weiner

5E10: a prostate-specific surface-reactive monoclonal antibody.

scientific article published on September 1998

A genetic screen to identify gain- and loss-of-function modifications that enhance T-cell infiltration into tumors

scientific article published on 01 July 2020

A genome-wide association study of marginal zone lymphoma shows association to the HLA region

scientific article

A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90 yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.

scientific article

AACR Cancer Progress Report 2013.

scientific article published on 16 September 2013

AACR Cancer Progress Report 2014

scientific article

Academic Cancer Center Phase I Program Development

scientific article

Active choice but not too active: public perspectives on biobank consent models.

scientific article

Acute promyelocytic infiltration of the optic nerve treated by oral trans-retinoic acid

scientific article published on September 1992

An RNA Aptamer-Based Biomarker Platform Demonstrates High Soluble CD25 Occupancy by IL2 in the Serum of Follicular Lymphoma Patients

scientific article published on 05 August 2019

Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

journal article published in 2015

Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab.

scientific article published on 6 July 2006

Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms

scientific article

Antibody Opsonization of a TLR9 Agonist-Containing Virus-like Particle Enhances In Situ Immunization

scientific article published on 17 January 2020

Antibody therapy of lymphoma

scientific article published on 01 January 2004

B-CLL cells acquire APC- and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21

scientific article

B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides

scientific article published on 01 February 2005

B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation.

scientific article published on 29 June 2006

Biodegradable microparticles loaded with doxorubicin and CpG ODN for in situ immunization against cancer

scientific article

Bispecific antibodies in cancer therapy

scientific article

Bispecific monoclonal antibody therapy of B-cell malignancy

scientific article

Building better monoclonal antibody-based therapeutics.

scientific article published in June 2015

CD16 polymorphisms and NK activation induced by monoclonal antibody-coated target cells.

scientific article published on September 2005

Cancer and inflammation: promise for biologic therapy.

scientific article

Cancer biology--lost in translation?

scientific article published on 5 July 2004

Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge.

scientific article

Cancer immunotherapy comes of age

scientific article published on 31 October 2011

Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL c

scientific article

Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study.

scientific article published on 18 August 2017

Complement and cellular cytotoxicity in antibody therapy of cancer

scientific article published on 01 June 2008

Complement in monoclonal antibody therapy of cancer

scientific article

Complement-Regulatory Proteins CFHR1 and CFHR3 and Patient Response to Anti-CD20 Monoclonal Antibody Therapy.

scientific article published on 15 August 2016

Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma

scientific article

CpG DNA and cancer immunotherapy: orchestrating the antitumor immune response

scientific article published on November 2003

CpG Oligodeoxynucleotides Enhance Monoclonal Antibody Therapy of a Murine Lymphoma ⬇️

scientific article published on 01 June 2000

CpG oligodeoxynucleotide-based therapy of lymphoid malignancies.

scientific article published on 08 January 2009

CpG oligodeoxynucleotides as immunotherapy in cancer.

scientific article published on March 2008

CpG oligodeoxynucleotides enhance FcgammaRI-mediated cross presentation by dendritic cells.

scientific article published on 10 June 2004

CpG oligonucleotides as immunotherapeutic adjuvants: innovative applications and delivery strategies.

scientific article published on 7 January 2009

CpG oligonucleotides enhance the tumor antigen-specific immune response of an anti-idiotype antibody-based vaccine strategy in CEA transgenic mice

scientific article published on 26 July 2005

Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials.

scientific article published on 19 April 2018

Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.

scientific article published on 27 July 2016

Early treatment of high risk chronic lymphocytic leukemia with alemtuzumab, rituximab and poly-(1-6)-beta-glucotriosyl-(1-3)- beta-glucopyranose beta-glucan is well tolerated and achieves high complete remission rates

scientific article

Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma.

scientific article published on 17 October 2011

Elevated soluble IL-2Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma

scientific article

Essential Components of Cancer Education

scientific article

GA101 induces NK-cell activation and antibody-dependent cellular cytotoxicity more effectively than rituximab when complement is present

scientific article published on 16 April 2013

Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy

scientific article published on 12 October 2015

Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region

scientific article published in October 2014

Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia

scientific journal article

Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma

scientific article

Germline variation in complement genes and event‐free survival in follicular and diffuse large B‐cell lymphoma ⬇️

scientific article published on June 20, 2012

Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion.

scientific article

Helminth-Induced Production of TGF-β and Suppression of Graft-versus-Host Disease Is Dependent on IL-4 Production by Host Cells

article

Identification of candidate B-lymphoma genes by cross-species gene expression profiling

scientific article

Immunoscintigraphy with 111In-satumomab pendetide in patients with colorectal adenocarcinoma: performance and impact on clinical management

scientific article published in February 1994

Immunostimulatory CpG oligodeoxynucleotides and antibody therapy of cancer

scientific article

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization ⬇️

scientific article published on September 30, 1997

Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.

scientific article published on 6 December 2004

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

scientific article published on 01 April 2020

Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice.

scientific article

Introduction: bispecific antibodies

scientific article published on 01 February 2001

Making a better antibody: all is not lost

scientific article published on 01 June 2010

Manipulation of cellular redox parameters for improving therapeutic responses in B‐cell lymphoma and multiple myeloma ⬇️

scientific article published on February 1, 2012

Measuring granulocyte and monocyte accumulation at malignant lymphoma sites

scientific article published on 24 November 2008

Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia

scientific article published on 9 March 2016

Minimally differentiated acute leukemia

scientific article published in March 1993

Monoclonal antibodies in the treatment of human B-cell malignancies.

scientific article published in October 1998

Monoclonal antibody mechanisms of action in cancer.

scientific article published on January 2007

Monoclonal antibody therapy of B cell lymphoma

scientific article published on March 2004

Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas ⬇️

scientific article published on November 3, 2011

NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement.

scientific article

Outcomes among US patients with diffuse large B cell lymphoma are independent of tumor Epstein Barr virus positivity or immunosuppression

scientific article published on 23 November 2017

Persistent thrombocytopenia during remission in acute leukemia does not preclude long-term disease-free survival

scientific article published on 01 November 2002

Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia

scientific article

Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma

scientific article published on 01 October 2007

Phosphorothyoate oligodeoxynucleotides block nonspecific binding of Cy5 conjugates to monocytes.

scientific article

Picking the optimal target for antibody-drug conjugates

scientific article

Quantification of Receptor Occupancy by Ligand-An Understudied Class of Potential Biomarkers

scientific article published on 13 October 2020

Radioimmunoscintigraphy with 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence

scientific article published on 01 November 1994

Radiolabeled antibody imaging of patients with potentially resectable colorectal adenocarcinoma

scientific article published on 01 January 1994

Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL

scientific article published on 01 March 1997

Relationships between chemotherapy, chemotherapy dose intensity and outcomes of follicular lymphoma in the immunochemotherapy era: a report from the University of Iowa/Mayo Clinic Lymphoma Specialized Program of Research Excellence Molecular Epidemi

scientific article

Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism.

scientific article

Rituximab: mechanism of action

scientific article

Short telomeres in B-CLL: the chicken or the egg?

scientific article published in June 2008

Synergism between cytosine-guanine oligodeoxynucleotides and monoclonal antibody in the treatment of lymphoma.

scientific article

T-cell activation induced by anti-CD3 × anti-B-cell lymphoma monoclonal antibody is enhanced by pretreatment of lymphoma cells with soluble CD40 ligand ⬇️

scientific article published on 01 November 1997

The effects of CpG ODN on CLL proliferation, apoptosis or phenotype could have an impact on its clinical utility

scientific article published on 26 July 2007

The safety and pharmacokinetics in adult subjects of an intravenously administered 99mTc-labeled 17 amino acid peptide (CYT-379)

scientific article published on 01 February 1994

Three steps to breaking immune tolerance to lymphoma: a microparticle approach.

scientific article

Uses of granulocyte-macrophage colony-stimulating factor in vaccine development

scientific article

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

scientific article

Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma.

scientific article

Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma.

scientific article

Widespread use of complementary and alternative medicine among non-Hodgkin lymphoma survivors.

scientific article

Paulina is supported by:

About Paulina

Help